Clover Health Investments, Corp.
CLOV
NASDAQ·Healthcare·Medical - Healthcare Plans·Mkt cap $2.2B
$4.26
▲ 0.00%
P/E
-129.33
Mkt Cap
$2.2B
52-Wk Range
$1.58–$5.59
52-Week Range
$1.58 - $5.59
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 55.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Clover Assistant AI platform for care optimization and cost reduction
- Technology-driven approach to Medicare Advantage differentiation
- Data analytics capabilities for improved member health outcomes
- Direct-to-consumer digital engagement and enrollment
Bear Case
2 risks
- High volatility (beta 2.5). Larger-than-normal price swings expected.
- Extreme premium - high expectations embedded
Growth
Turning profitable
Expanding Medicare Advantage market with aging Baby Boomer population
Value
Extreme premium - high expectations embedded
Momentum
Strong
+8.6% over 3m
Quality
Thin
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CLOV right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of $0.07 vs $0.04 consensus (+88.0% surprise). Revenue of $743.2M vs $728.3M expected (+2.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+88.0%
Revenue trend · last 8Q
—
-34%
+33%
+34%
+50%
+45%
+61%
+56%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$331.0M
$337.0M
$462.3M
$477.6M
$496.6M
$487.7M
$744.2M
$743.2M
Margins · last 8Q
Gross
—
Operating
3.8%
Profit
3.8%
Wall Street consensus
2 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: UBS · Aug 6, 2026
vs Industry
How CLOV stacks vs Medical - Healthcare Plans
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related